Objective-Here, we provide evidence for the role of FLNA (filamin A) in the modulation of store-operated calcium entry (SOCE). Approach and Results-SOCE is a major mechanism for calcium influx controlled by the intracellular Ca 2+ stores. On store depletion, the endoplasmic reticulum calcium sensor STIM1 (stromal interaction molecule 1) redistributes into puncta at endoplasmic reticulum/plasma membrane junctions, a process supported by the cytoskeleton, where it interacts with the calcium channels; however, the mechanism for fine-tuning SOCE is not completely understood. Our results demonstrate that STIM1 interacts with FLNA on calcium store depletion in human platelets. The interaction is dependent on the phosphorylation of FLNA at Ser 2152 by the cAMP-dependent protein kinase. Impairment of FLNA phosphorylation and knockdown of FLNA expression using siRNA increased SOCE in platelets. Similarly, SOCE was significantly greater in FLNA-deficient melanoma M2 cells than in the FLNA-expressing M2 subclone A7. Expression of FLNA in M2 cells attenuated SOCE, an effect prevented when the cells were transfected with the nonphosphorylatable FLNA S2152A mutant. Transfection of M2 cells with the STIM1(K684,685E) mutant reduced the STIM1-FLNA interaction. In platelets, attenuation of FLNA expression using siRNA resulted in enhanced association of STIM1 with the cytoskeleton, greater STIM1-Orai1 interaction, and SOCE. Introduction of an anti-FLNA (2597-2647) antibody attenuated the STIM1-FLNA interaction and enhanced thrombin-induced platelet aggregation. 
S tore-operated calcium entry (SOCE) is a major mechanism for calcium influx triggered by depletion of the intracellular Ca 2+ stores, a phenomenon that is sensed by the proteins of the STIM family, with a predominant role of the STIM1 (stromal interaction molecule 1).
1 STIM1 is a protein with a single transmembrane domain located in the endoplasmic reticulum (ER), 2 the lysosomal like acidic Ca 2+ stores, 3 and the plasma membrane. 4, 5 On Ca 2+ store depletion, that is, by inhibition of the Ca 2+ -ATPase SERCA using thapsigargin, ER-resident STIM1 forms oligomers and distributes into puncta at the ER/plasma membrane (PM) junctions. [6] [7] [8] [9] Activation of Ca 2+ release-activated channels (CRAC) requires that STIM1 undergoes a conformational change from a closed to an extended state, which facilitates the communication with the channels. 10 Redistribution of STIM1 into puncta involves the association with the cytoskeleton and movement along the microtubules. 11 Furthermore, maneuvers aimed at disorganizing or stabilizing the cytoskeleton have resulted in impairment of the STIM1-Orai1 interaction and SOCE. 12, 13 FLNA (Filamin A) is a 2647-amino acid-long actin-crosslinking protein, with 2 N-terminal actin-binding domains followed by 24 immunoglobulin-like repeats.
14 FLNA is mostly located in the membrane cytoskeleton, underneath the PM, where it has been found to regulate a variety of cytoskeletonrelated processes, including receptor clustering and cross talk among different receptors and the actin cytoskeleton.
14 FLNA has been found to be phosphorylated by PKA (protein kinase A), 15 and FLNA phosphorylation at Ser 2152 , located in the Ig20 repeat, by PKA is essential for many cellular functions, such as cytoskeleton remodeling, cell migration, and platelet aggregation. [16] [17] [18] Mouse models with deficient expression of FLNA have been found to show platelets that fail to spread, have decreased α-granule secretion and protein tyrosine phosphorylation, and exhibit hyperaggregability and thrombocytopenia because of platelet loss, 19, 20 which indicates that FLNA plays a functional role in platelets.
Here, we have investigated the possible function of FLNA on the STIM1-Orai1 interaction and SOCE. We have found that on Ca 2+ store depletion, STIM1 interacts with FLNA in human platelets in a Ca 2+ -dependent manner, which requires phosphorylation at FLNA Ser 2152 . FLNA expression knockdown results in clustering of STIM1 in the cytoskeletal fraction and enhancement of STIM1-Orai1 interaction, as well as SOCE and platelet function. These findings indicate that FLNA plays an essential role in the cross talk between STIM1 and Orai1 and modulates SOCE, avoiding Ca 2+ overload, and then ensuring a correct platelet function.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Identification of FLNA as a New STIM1-Associated Protein
To ascertain whether FLNA is associated with STIM1 on Ca 2+ store depletion, human platelets were stimulated with 1 µmol/L thapsigargin in the presence of 1 mmol/L extracellular Ca 2+ or left untreated and lysed after 30 seconds. Whole-cell lysates were precleared with protein A-agarose and immunoprecipitated with anti-STIM1 antibody. We identified a band >150 kDa whose association with STIM1 was modified after treatment with thapsigargin with apparent molecular mass of ≈280 kDa ( Figure 1A ). The 280-kDa band was analyzed by MALDI TOF/TOF (matrix-assisted laser desorption/ionization time-offlight) mass spectrometry at the Biotechnology National Center (Madrid, Spain) yielding the results presented in the Table. The protein with the highest score was identified as FLNA, and the score provided for the remaining proteins was relatively low; hence, we analyzed the FLNA-STIM1 interaction.
FLNA Coimmunoprecipitates With STIM1 in a Ca
2+ -Dependent Manner
Immunoprecipitation and subsequent Western blotting were conducted in platelets suspended in a medium containing 1 mmol/L Ca 2+ and in platelets heavily loaded with dimethyl-BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,Nʹ,Nʹ-tetraacetic acid), to prevent Ca -dependent manner. A, Human platelets were treated with 1 µmol/L thapsigargin (TG) for 30 s and lysed. Platelet lysates were precleared by incubation for 1 h with protein A-agarose and then were immunoprecipitated with anti-STIM1 antibody. Immunoprecipitated proteins were separated by SDS/PAGE followed by silver staining of the gel as described in the Materials and Methods section in the onlineonly Data Supplement. Positions of molecular-mass markers are shown on the left. B and C, Platelets were loaded with dimethyl BAPTA or left untreated and suspended in a Ca FLNA phosphorylation at residue 2152 has been reported to play a crucial role in its biological functions. [21] [22] [23] (Figures 2A and 2B, bottom) .
We have further explored whether FLNA phosphorylation at Ser 2152 evoked by store depletion is dependent on PKA, as previously reported under other conditions, 24 by using KT-5720, which impairs PKA activation in human platelets. 26 As depicted in Figures 2D and 2F ] c after the addition of CaCl 2 were 74 072±6442 and 107 404±1750 nM·s in the absence and presence of KT-5720; Figure 3F ; P<0.05). These findings suggest that impairment of the association between STIM1 and FLNA, by dephosphorylation of the latter, results in a significant increase in SOCE. To further explore the role of FLNA phosphorylation at Ser 2152 on SOCE, we tested the effect of brefeldin A. As shown in Figure 3E , platelet treatment with brefeldin A significantly attenuated SOCE without having any effect on thapsigargin-induced Ca 
FLNA Plays a Relevant Role in the Modulation of Store-Operated Ca 2+ Entry
The use of KT-5720 and brefeldin A provides indirect evidence for the involvement of FLNA on SOCE. Hence, we have more directly evaluated the role of FLNA in SOCE by using interference RNA-based technology. siRNA has previously been proven to be an efficient technique for silencing the expression of platelet proteins. 27 In human platelets, transfection with FLNA siRNA significantly attenuated the expression of FLNA at the protein level after 24 hours ( Figure 4A ; P<0.05; n=3). To explore the role of FLNA on SOCE, platelets were transfected with FLNA siRNA, scramble target sequence (siRNA A), or left untreated. As shown in Figure 4B , the resting, as well as thapsigargin-evoked Ca 2+ release from the stores, was not affected by any of the experimental maneuvers ( Figures 4B and 4C) 
FLNA Modulates the Location of STIM1 in the Cytoskeletal Fraction and the Interaction With Orai1
Because FLNA is a cytoskeletal protein, we have explored whether it modulates the association of STIM1 with the platelet cytoskeleton. As shown in Figure 5A , attenuation of FLNA expression significantly enhanced the location of STIM1 in the cytoskeletal fraction (P<0.05; n=6). Consistent with this, the expression of STIM1 in the cytosolic and membrane fraction was reduced in cells transfected with FLNA siRNA (Figure 5B ; P<0.05; n=6). These findings indicate that FLNA modulates the association of STIM1 with the cytoskeleton. As we have previously reported that the cytoskeleton plays a relevant role in the interaction between STIM1 and Orai1, 12 we have investigated the role of FLNA in the association of STIM1 with Orai1 in platelets transfected with FLNA siRNA or siRNA A and then stimulated with thapsigargin or left untreated. After immunoprecipitation with anti-STIM1 antibody, Western blotting revealed the presence of Orai1 in samples from resting platelets transfected with scramble siRNA, which was significantly enhanced by 32±9% on treatment with thapsigargin ( Figure 5C ; P<0.05; n=6). Interestingly, both resting and thapsigargin-evoked STIM1-Orai1 association was significantly greater in platelets transfected with FLNA siRNA ( Figure 5C ; P<0.05; n=6), indicating that FLNA regulates SOCE by modulating the association of STIM1 with the cytoskeleton and, subsequently, STIM1-Orai1 interaction.
We have further explored the role of FLNA on ex vivo platelet aggregation in response to the physiological agonist thrombin. Human platelets transfected with siRNA A or FLNA siRNA for 24 hours were stimulated with 1 U/mL thrombin in a medium containing 1 mmol/L Ca FLNA siRNA (P<0.05; n=6), indicating that FLNA modulates platelet aggregation probably by regulating Ca 2+ signaling.
FLNA Modulates SOCE in Melanoma Cells Through Phosphorylation at Residue 2152
To confirm the regulatory role of FLNA in SOCE observed in human platelets, we have used the FLNA-deficient melanoma cell line M2 and the FLNA-expressing M2 subclone A7. 28 As shown in Figure 6A , top, FLNA was strongly detected in A7 cells but was undetectable in the M2 cell line. In A7 cells, our results indicate that treatment with the agonist endothelin-1 (10 nM) for 30 and 60 seconds significantly enhances FLNA phosphorylation at Ser 2152 ( Figure 6B ; P<0.05; n=6), in agreement with previous studies reporting that G protein-coupled receptors induce recruitment and phosphorylation of FLNA, an event that has long been known to be essential for the regulation of the structure and dynamics of the actin cytoskeleton. Figure 6C and 6D, SOCE was significantly greater in FLNAdeficient M2 cells (the integrals of the rise in fura-2 fluorescence ratio after the addition of CaCl 2 were 58.4±2.1 and 44.6±1.4 au·s in M2 and A7 cells, respectively; P<0.05; n=6). These observations are consistent with the results obtained in human platelets and further support that FLNA regulates the activation of SOCE. Thapsigargin-evoked Ca 2+ efflux from the internal stores was also found to be greater in M2 cells (the integrals of the rise in fura-2 fluorescence ratio after the addition of thapsigargin were 67.5±1.1 and 36.1±0.9 au·s in M2 and A7 cells, respectively; P<0.05; n=6). This observation might be a consequence of the greater SOCE in these cells, although we cannot exclude a possibility of a modulatory role of FLNA on Ca 2+ store refilling by SERCA. To assess this possibility, cells were stimulated with endothelin-1 in a Ca 2+ -free medium followed by addition of thapsigargin to estimate the ability of the cells to store Ca 2+ . As depicted in Figure 6E and 6F, treatment of A7 and M2 cells with endothelin-1 (10 nM) induced a transient increase in [Ca 2+ ] c , subsequent addition of thapsigargin induced a further rise in [Ca 2+ ] c indicative of the amount of Ca 2+ accumulated in the stores. Both, endothelin-1-evoked and thapsigarginevoked responses were greater in M2 cells (the integrals of the rise in fura-2 fluorescence ratio after the addition of endothelin-1 were 28.4±1.6 and 11.4±1.9 ua·s in M2 and A7 cells, respectively, and that of the thapsigargin-induced responses were 13.6±1.2 and 6.2±0.5 ua·s in M2 and A7 cells, respectively; P<0.05; n=6), which indicates that the ability to refill the stores is greater in FLNA-deficient M2 and suggests that FLNA might regulate SERCA activity in these cells.
We have further explored whether phosphorylation of FLNA at Ser 2152 is involved in the modulation of SOCE in melanoma cells as reported above in human platelets. To investigate this possibility, M2 cells were transfected with expression plasmids for wild-type FLNA or the nonphosphorylatable FLNA S2152A mutant ( Figure 7A ). As shown in Figure 7B and 7C, expression of FLNA in M2 cells significantly attenuated SOCE (the integrals of the rise in fura-2 fluorescence ratio after the addition of CaCl 2 were 42.2±2.2 and 28.5±2.2 ua·s in M2 and FLNA-expressing M2 cells, respectively; P<0.05; n=6), which further confirms the modulatory role of FLNA on SOCE. By contrast, expression of the nonphosphorylatable FLNA mutant was without effect on thapsigargin-induced Ca 2+ release and entry (the integral of the rise in fura-2 fluorescence ratio after the addition of CaCl 2 was 40.7±3.2 ua·s in FLNA S2152A-expressing M2 cells; n=6), thus suggesting that the role of FLNA on these processes entirely depends on phosphorylation at Ser
2152
. The attenuation of thapsigargin-evoked Ca 2+ release from the stores induced by the expression of FLNA was also impaired by the S2152A mutation (the integrals of the rise in fura-2 fluorescence ratio after the addition of thapsigargin were 41.4±2.2, 32.1±1.4, and 40.3±3.2 ua·s in M2, FLNA-expressing M2, and FLNA S2152A-expressing M2 cells, respectively; P<0.05; n=6).
C-Terminal Domain of STIM1 and Filamin A Dimerization Are Essential for Their Interaction and Platelet Function
We have finally analyzed the location of the STIM1-and FLNAbinding sites. STIM1 shows a polybasic lysine-rich domain in the C-terminal region that is involved in the interaction with TRPC1 channels 30 and phosphoinositides at the plasma membrane. 31 Hence, we have investigated whether this region is responsible for the interaction with FLNA in M2 cells overexpressing pEYFP-STIM1 (full-length) or the pEYFP-STIM1(K684,685E) mutant together with FLNA. As shown in Figure 8A , our results indicate that coexpression of pEYFP-STIM1 and FLNA show detectable coimmunoprecipitation between both proteins at rest, which was enhanced by treatment with thapsigargin. Interestingly, STIM1-FLNA interaction was abolished in cells coexpressing FLNA and the STIM1(K684,685E) mutant, which strongly indicates that the lysine-rich region of STIM1 is required for FLNA interaction. Similarly, we have investigated the location of the relevant STIM1-interacting FLNA site. The C-terminal region of FLNA is especially important for the interaction with signaling molecules, and many of these interactions occur at the 24th dimerizing repeat of FLNA 32 ; therefore, we have investigated whether this region is important for the interaction with STIM1. To assess this possibility, the anti-FLNA antibody, which recognizes the sequence between residues 2597 and 2647, was introduced into platelets by electropermeabilization, as described previously. 5 The internalization of the antibody was investigated in samples from electropermeabilized cells incubated with 4 µg/mL anti-FLNA (2597-2647) antibody, by immunoprecipitation without adding any additional anti-FLNA antibody and subsequent Western blotting with the anti-FLNA (2597-2647) antibody ( Figure 8B ). As shown in Figure 8C , interaction between STIM1 and FLNA was significantly attenuated in cells transjected with 4 µg/mL anti-FLNA (2597-2647) antibody (top, lanes 1 and 2) compared with cells transjected with a rabbit IgG (top, lanes 3 and 4) used as control because this is the nature of the anti-FLNA (2597-2647) antibody. The FLNA-STIM1 interaction was reduced by 82% and 74% in resting and thapsigargin-treated cells, respectively, in cells transjected with the anti-FLNA (2597-2647) antibody compared with control (cells transjected with rabbit IgG; P<0.05; n=6). Reprobing of the same membranes with anti-STIM1 antibody confirmed a similar protein loading in all lanes ( Figure 8C,  bottom) . These findings indicate that the FLNA 2597 to 2647 sequence, located in the dimerizing repeat, is relevant for the STIM1-FLNA interaction and suggest that dimerization of FLNA is necessary for the interaction.
Because introduction of the anti-FLNA (2597-2647) antibody impairs the STIM1-FLNA interaction, we have investigated whether this interaction is important for platelet aggregation. As shown in Figure 8D , introduction of the anti-FLNA (2597-2647) antibody into platelets significantly enhanced the amplitude and slope of thrombin-induced platelet aggregation compared with transjection of a rabbit IgG. These findings indicate that the STIM1-FLNA interaction plays a relevant functional role in human platelets.
Discussion
SOCE is a complex mechanism for Ca 2+ influx controlled by the Ca 2+ stores. Although the central event is based on the interaction between STIM1 and the store-operated channels at ER-PM junctions, many proteins fine-tune the amplitude of Ca 2+ entry, an essential process for different cellular functions, including platelet physiology, 33, 34 B-cell response, 35 or neuronal differentiation. 36 Key modulators of STIM1-Orai1 interaction include CRACR2A, STIMATE, SARAF, septins, or ORMDL3, among others. 37 More precisely, STIM1-Orai1-supporting proteins include CRACR2A, which stabilizes the SOCE signalplex, STIMATE, required for the activation and translocation of STIM1, and septins, involved in the organization of membrane microdomains important for STIM1-Orai1 interaction. Among the negative modulators of SOCE are SARAF, ORMDL3 or golli, which prevent excessive Ca 2+ influx. 37 The SOCE signalplex is supported by the cytoskeleton, [11] [12] [13] which is rapidly remodeled on store depletion. 38 18 We have found that impairment of FLNA phosphorylation enhances SOCE, meanwhile inhibition of FLNA dephosphorylation leads to the opposite effect, thus suggesting that FLNA might be a negative modulator of SOCE in platelets. We have confirmed the role of FLNA in SOCE in platelets using siRNA. Platelets carry out mRNA translation, a process that is relevant for platelet-mediated thrombosis and hemostasis, 39 and siRNA has been demonstrated to be efficiently introduced into platelets to modulate protein expression in these cells. 27 Our results indicate that 24 hours after transfection of the FLNA siRNA, FLNA expression was significantly reduced. Further transfection periods led to a significant reduction in cell viability (data not shown). Interestingly, attenuation of FLNA expression revealed that FLNA is a modulator of SOCE in human platelets. This function was confirmed in the FLNA-deficient melanoma cell line M2 where SOCE was greater than that in the FLNAexpressing M2 subclone A7. To our knowledge, this is the description of a role for FLNA in the modulation of SOCE. We also found that FLNA modulates Ca 2+ uptake into the intracellular stores by SERCA, whereas this effect seems to be specific for melanoma cells, because this function was not observed in human platelets, we cannot exclude a possible role of FLNA on SERCA in platelets that can be difficult to detect because of the low rate of Ca 2+ efflux from the stores in these cells on treatment with thapsigargin. Using melanoma cells, we have also confirmed that phosphorylation of FLNA at Ser 2152 is essential for the regulation of SOCE, in agreement with the observations in human platelets.
Our results indicate that the C-terminal regions of STIM1 and FLNA play a relevant role in the interaction with each other, as mutation of the STIM1 lysine-rich domain and interference with the FLNA 2597 to 2647 region impair the STIM1-FLNA association.
Finally, we have investigated the regulatory mechanism of FLNA. Because FLNA is an actin-binding protein, we have initially investigated its role in the location of STIM1 in the cytoskeletal fraction. We have found that FLNA expression knockdown enhances the association of STIM1 with the cytoskeleton and subsequently increases the interaction of STIM1 with Orai1, leading to a dramatic increase in SOCE. Furthermore, impairment of FLNA-STIM1 interaction results in enhanced platelet aggregation in response to agonists. These findings strongly suggest that FLNA might be essential for an appropriate association of STIM1 with the cytoskeleton, which, in turn, is necessary to fine-tune the interaction with the store-operated channels and SOCE and also to modulate platelet function. Previous studies in a mouse model with deficient expression of FLNA have revealed that platelets exhibit hyperaggregability and thrombocytopenia because of platelet loss. 19, 20 Furthermore, a recent study has reported that a patient carrying a mutation that results in a 100-amino acidlong FLNA C-terminal extension (p.Ter2648SerextTer101) showed normal platelet count but upregulated platelet function. 40 Our results provide evidence that a deficient expression or function of FLNA in platelets might alter Ca 2+ homeostasis, which, in turn, might underlie platelet function disorders.
